The Binding Site & Rockland Immunochemicals Enter into Distribution Agreement

UK based specialist diagnostic manufacturer, The Binding Site Group Ltd, is pleased to announce that it has entered into an exclusive, definitive agreement with Rockland Immunochemicals, Inc., of Limerick, PA, to grant Rockland global distribution rights for Binding Site’s line of animal-focused radial immunodiffusion (RID) test kits.

The availability of this unique range of products exclusively through Rockland will benefit the needs of laboratory professionals conducting basic, applied, and clinical research in the veterinary, biomedical, life-science, genomics, and drug discovery fields.

Radial immunodiffusion is a robust assay used to determine the concentration of an antigen, or protein, in a biological sample. The estimated $75 billion monoclonal antibody market combined with the growing number of biosimilars is driving increased demand for critical testing reagents, kits and assays. The RID Immunoassay kits are easy to use and incorporate monospecific antibodies in an agarose gel, to provide accurate quantitation. Terri Poole, Chief Commercial Officer at Rockland Immunochemicals, Inc., states, “Our customers trust that Rockland will provide the most relevant products for their research. These RID kits are a perfect addition to our constantly expanding product portfolio and will benefit our clientele across the life science industry.”

Julia Nisbet-Fahy, Binding Site’s Global Business Manager for their Immunologicals Group, commenting on the Agreement, remarks; "A proven track record, industry knowledge, and technical expertise in the research market were the primary motivators in our selection of Rockland to adopt and distribute these products. The combined goal of our partnership is to provide customers accurate and reliable products. Binding Site is confident of our joint success."